Rituximab in B-Cell chronic lymphocytic leukemia
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (4) , 483-492
- https://doi.org/10.1016/s0093-7754(03)00239-2
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Activity of Oral Fludarabine Phosphate in Previously Treated Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2001
- Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2001
- Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesBlood, 2000
- Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial TherapyBlood, 1998
- Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo ChemoresponsesBlood, 1998
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisoneCancer, 1985
- Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemiaBlood, 1977